Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8664631 | 0.92 | AOC2 (0.36) | ALDH1A1HTTS1PR3SNCAPTGER4 | |
| SCHEMBL5861877 | 0.92 | AOC2 (0.36) | ALDH1A1HTTS1PR3SNCAPTGER4 | |
| SCHEMBL10317771 | 0.91 | S1PR3 (0.37) | ALDH1A1HTTS1PR3SNCAHPGD | |
| SCHEMBL9010034 | 0.89 | PTGS2 (0.38) | ALDH1A1S1PR3SNCAHSD17B10LMNA | |
| SCHEMBL8750988 | 0.88 | S1PR3 (0.41) | ALDH1A1HTTS1PR3HPGDMAPT | |
| SCHEMBL10596213 | 0.86 | ALDH1A1 (0.41) | ALDH1A1HTTSNCAHSD17B10LMNA | |
| SCHEMBL900004 | 0.84 | GAA (0.38) | ALDH1A1HTTS1PR3SNCAHSD17B10 | |
| SCHEMBL6543321 | 0.83 | LMNA (0.39) | ALDH1A1HTTS1PR3SNCAHSD17B10 | |
| SCHEMBL29006523 | 0.83 | PTGS2 (0.45) | S1PR3SNCAKDM4E | |
| SCHEMBL8958833 | 0.83 | ALDH1A1 (0.36) | ALDH1A1HTTS1PR3SNCAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3053944-B1 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | SHINETSU CHEMICAL CO (JP) | 2021-10-06 | — | — | EP | disclosed |
| US-11053222-B2 | Fluorescent compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2021-07-06 | — | — | US | disclosed |
| US-10730857-B2 | Benzocyanine compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2020-08-04 | — | — | US | disclosed |
| US-10696653-B2 | Cyanine compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2020-06-30 | — | — | US | disclosed |
| US-10472377-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-11-12 | — | — | US | disclosed |
| US-10351551-B2 | Fluorescent compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| EP-3081564-B1 | INDOLE DERIVATIVES AS LABELING DYE FOR BIOMOLECULE | PIERCE BIOTECHNOLOGY INC (US) | 2019-07-10 | — | — | EP | disclosed |
| US-20190084964-A1 | Benzocyanine Compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2019-03-21 | — | — | US | disclosed |
| US-20180327387-A1 | Cyanine Compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2018-11-15 | — | — | US | disclosed |
| US-10125120-B2 | Benzocyanine compounds | PIERCE BIOTECHNOLOGY, INC. (US) | 2018-11-13 | — | — | US | disclosed |
| EP-0663391-B1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | HOFFMANN LA ROCHE (CH) | 1997-04-09 | — | — | EP | disclosed |
| US-5567783-A | FLEXIBLE, AMORPHOUS POLYMER; SOLID ELECTROLYTES | THE PENN STATE RESEARCH FOUNDATION (US) | 1996-10-22 | — | — | US | disclosed |
| WO-1996027630-A1 | IONICALLY CONDUCTIVE POLYPHOSPHAZENES WITH ETHER SIDEGROUPS | THE PENN STATE RESEARCH FOUNDATION (US) | 1996-09-12 | — | — | WO | disclosed |
| EP-0663391-A1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | F. HOFFMANN-LA ROCHE AG (CH) | 1995-07-19 | — | — | EP | disclosed |
| US-4761475-A | 2,4-diaminopyrimidines substituted with heterobicyclomethyl radicals at the 5 position useful as antibacterials | SCHERING-PLOUGH ANIMAL HEALTH CORPORATION | 1988-08-02 | — | — | US | disclosed |
| US-4616015-A | HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-10-07 | — | — | US | disclosed |
| US-4587342-A | 2,4-diamino-(substituted-benzopyran(quinolyl,isoquinoly)methyl)pyrimidines useful as antibacterials | SCHERING-PLOUGH ANIMAL HEALTH CORPORATION | 1986-05-06 | — | — | US | disclosed |
| EP-0051879-B1 | SUBSTITUTED PYRIMIDINES, THEIR SYNTHESIS AND COMPOSITIONS CONTAINING THEM, THEIR USE IN MEDICINE AND INTERMEDIATES FOR MAKING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-02-05 | — | — | EP | disclosed |
| EP-0122627-A2 | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-24 | — | — | EP | disclosed |
| EP-0051879-A2 | Substituted pyrimidines, their synthesis and compositions containing them, their use in medicine and intermediates for making them | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351551-B2 | Fluorescent compounds | NCL, FUS, EFTUD2 | ALDH1A1 2481/4885HTT 107/4885S1PR3 4213/4885 |
| US-20180327387-A1 | Cyanine Compounds | NCL, NOP58, NAT10 | ALDH1A1 3956/4885HTT 218/4885S1PR3 4450/4885 |
| US-10472377-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | ADH1A, ADH1C, AP3M1 | ALDH1A1 51/4885HTT 4409/4885S1PR3 3140/4885 |
| US-10696653-B2 | Cyanine compounds | NCL, NOP58, NAT10 | ALDH1A1 3956/4885HTT 218/4885S1PR3 4450/4885 |
| US-10730857-B2 | Benzocyanine compounds | TBCA, BCAT1, BCAT2 | ALDH1A1 2580/4885HTT 132/4885S1PR3 4437/4885 |
| US-10125120-B2 | Benzocyanine compounds | TBCA, BCAT1, BCAT2 | ALDH1A1 2580/4885HTT 132/4885S1PR3 4437/4885 |
| US-11053222-B2 | Fluorescent compounds | NCL, FUS, EFTUD2 | ALDH1A1 2481/4885HTT 107/4885S1PR3 4213/4885 |
| US-20190084964-A1 | Benzocyanine Compounds | TBCA, BCAT1, BCAT2 | ALDH1A1 2580/4885HTT 132/4885S1PR3 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.